Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
DVDaVita Inc. logo

DaVita Inc. (DVA)

New York Stock Exchange · Currency in USD
$183.64 ▼ -2.46 (-1.32%)
At close: Oct 23, 4:00 PM ET. Market closed.
$184.00 ▲ +0.36 (+0.20%)
After hours: Oct 23, 4:51 PM ET

Summary

Previous Close
$186.10
Open
$184.52
Day's Range
$183.52 – $187.52
52 Week Range
$101.00 – $247.49
Volume
618,064
Avg. Volume
786,408
Market Cap
$11.72B
Beta (5Y Monthly)
0.80
PE Ratio (TTM)
15.79
EPS (TTM)
$13.08
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$235.67

Profile: DaVita Inc.

Sector
Healthcare
Industry
Medical - Care Facilities
Full-time employees
78,000
CEO
Javier J. Rodriguez
Website
davita.com

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD).

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $3.57 · Revenue est. $3.52B
DateEst.Actual
Aug 4, 2026$3.88$4.02Beat
May 5, 2026$2.41$2.87Beat
Feb 2, 2026$3.24$3.40Beat
Oct 29, 2025$3.17$2.51Miss
Aug 5, 2025$2.70$2.95Beat
May 12, 2025$1.95$2.00Beat

Analyst view

Consensus price target
$235.67 ▲ +28.3%
Range $215.00 – $270.00
Rating: Hold
Buy 43% · Hold 52% · Sell 4%

Similar stocks

Get free alerts on DVA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.